Table: begin end state 1 19 cytoplasmic 20 40 transmembrane 41 42 cytoplasmic 43 45 non-cytoplasmic 46 48 cytoplasmic 49 69 transmembrane 70 88 cytoplasmic 89 112 transmembrane 113 123 non-cytoplasmic 124 146 transmembrane 147 148 non-cytoplasmic 149 167 cytoplasmic 168 194 transmembrane 195 197 non-cytoplasmic 198 200 cytoplasmic 201 224 transmembrane 225 229 cytoplasmic 230 249 transmembrane 250 252 cytoplasmic 253 395 non-cytoplasmic 396 418 transmembrane 419 426 cytoplasmic 427 429 non-cytoplasmic 430 451 transmembrane 452 453 cytoplasmic 454 516 non-cytoplasmic 517 544 transmembrane 545 565 cytoplasmic 566 584 transmembrane 585 590 non-cytoplasmic 591 615 transmembrane 616 621 cytoplasmic 622 640 transmembrane 641 659 non-cytoplasmic 660 685 transmembrane 686 699 cytoplasmic
Input: >Ac3H11_204 FitnessBrowser__acidovorax_3H11:Ac3H11_204 MAERERSRVDSDRAYLWRLHRILALYVAGVLGFLALMTWAEHQGLSRHWIGPIFLFLTVM VYAGIGVYGRTTDPEDYYVAGRRIPPMYNGMATAADWMSAASFISLSGALYLQGFSGTPG QAGGLAYLLGWTGGFCLVAMLIAPHLRAMGLYTIPDFFHVRFGGRWPRVIAALAAVLCSF TYVVAQIYGVGLIASRLTGVQFEIGIMLGLGGVLLCSFLGGMRAITWTQVAQYVVLLLAF MIPVSWLAYKQLGNPLAPLVYGEQIGKIADLEAQLLDSPAEHQVVQAYLQRAKDFEARLQ NVEASLAHEREKGRERIRALRAQNADVGLIVAASRELAALPRDANAARERWTREMRENYE RARPLGGLPPHSQAYVGDPDGTPEEQRDYELTRRNFLALMFCLMVGTAGLPHLLTRFYTS PSVSAARASVGWSLFFIALLYLSAPALAVLVKFEVMQNLVGSSFEALPTWMAQWSRVDSS LLSLEDVNGDGLIQFGEIRLGADLIMLATPELGGLPYVVSGLVAAGGLAAALSTADGLLL TISNALVRDLYFQDSQRKASPEQRVILSKFALLAVALSAAFVAALKPSEILPMVSASFSL AASAFVPAMVLGIFWRGTTRQGAVAGMLTGLGIAVYYMLSHVPAVQGVLPRWLLADGLWF GIQPISAGVFGVPCGLLVTVVLSWMTRPAPALPRIRSEM
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server